New Fortress Energy
NFE
Ermenegildo Zegna NV
ZGN
Teradata Corp
TDC
4
Workday
WDAY
5
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
TIL Instil Bio
- 20.520
- +4.030+24.44%
Close Apr 23 16:00 ET
- 20.500
- -0.020-0.10%
Post 20:01 ET
134.59MMarket Cap-1.80P/E (TTM)
24.400High20.180Low500.13KVolume20.250Open16.490Pre Close11.12MTurnover18.50%Turnover RatioLossP/E (Static)6.56MShares92.00052wk High0.79P/B55.47MFloat Cap9.62052wk Low--Dividend TTM2.70MShs Float589.800Historical High--Div YieldTTM25.59%Amplitude6.060Historical Low22.230Avg Price1Lot Size
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Instil Bio Stock Forum
Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage PD-L1xVEGF Bispecific Antibody
Tuesday, 14th January at 7:00 am
ImmuneOnco announced dosing of first patient in its recently initiated Phase 1b/2 clinical trial of IMM2510/SYN-2510 in combination with chemotherapy in patients with advanced NSCLC in China
ImmuneOnco announced initial clinical data from the 1L advanced NSCLC trial in China is expected as early as 2H 2025
Instil is target...
keep 👀 $Instil Bio (TIL.US)$
Baird's optimism is driven by promising developments in Instil’s PD-L1xVEGF bispecific antibody, especially following positive data from peers like Akeso and Summit. Analysts believe this drug class has strong potentia...
Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF XBI 0.05% drop nearly 50%.
The other most-watched exchange-traded fund that tracks the biotech secto...
No comment yet